TOVX
Theriva Biologics
$0.21
−$0.01 (−4.48%)Jul 27, 2026
Key metrics
The numbers that frame TOVX today
- Market cap
- $9.78M
- P/E (TTM)
- -0.5
- EV / FCF
- 0.1
- Gross margin
- 100%
- EV / Sales
- -3.4
- ROIC
- -133.8%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $0.16
- 52wk High
- $0.86
Growth
Revenue and earnings trend for TOVX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TOVX
Is Theriva Biologics a good buy?
No. Theriva Biologics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of TOVX?
Theriva Biologics's market capitalization is $9.78M.
What is the P/E ratio for TOVX stock?
Theriva Biologics's current P/E ratio is -0.5.
What is the 52-week high for TOVX stock?
The 52-week high for Theriva Biologics is $0.86. The current close of $0.21 is 75.3% below that high.
What is the 52-week low for TOVX stock?
The 52-week low for Theriva Biologics is $0.16. The current close of $0.21 is 33.1% above that low.
Does TOVX stock pay dividends?
Theriva Biologics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TOVX?
Theriva Biologics's Debt / Equity ratio is 0.24.